GlassScriptPhysician profile
Ballan Tuck
NPI 1275613127
$3,631.84
in general payments reported to CMS, 2019-2025
11 companies · $946 in 2025
The $946 reported for 2025 was more than what 95% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $24.64 · 2022: $203 · 2023: $322 · 2024: $2,136 · 2025: $946.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,288 · Travel and Lodging: $1,116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,288.21 |
| Travel and Lodging | $1,116.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $2,045.22 | 2023-2025 | |
| Align Technology, INC. | $437.89 | 2022-2024 | Invisalign |
| Henry Schein, INC. | $270.93 | 2024 | |
| Straumann USA LLC | $212.53 | 2025 | |
| Solventum Corporation | $188.31 | 2025 | 3m Clinpro, Elipar Deepcure-S, Clarity Aligners |
| Ortho Organizers, INC. | $182.01 | 2021-2024 | Reveal Aligners |
| Dentsply Sirona INC | $147.70 | 2024-2025 | Suresmile, Cerec |
| Ultradent Products INC | $63.85 | 2022-2023 | Opalescence |
| Orapharma, A Division of Bausch Health US, LLC | $57.78 | 2022-2024 | Ossix Plus, Arestin |
| Philips North America LLC | $15.21 | 2022 | |
| Colgate Oral Pharmaceuticals, INC. | $10.41 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ballan Tuck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.